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Foot-and-mouth disease virus (FMDV) VP1 G–H loop contains the major antigenic site. By replacing the
sequence upstream of the RGD motif with a FLAG epitope, a marker virus for pathogenesis studies was
generated. In cell culture, the recombinant virus containing FLAG (A24-FLAG) exhibited similar plaque
phenotypes and growth kinetics to parental virus. A24-FLAG was distinguished, neutralized, and
immunoprecipitated by FLAG anti-sera. A24-FLAG infected cattle exhibited FMD and an antibody
response similar to parental virus. FLAG epitope stability was conﬁrmed both in vitro and in vivo.
Interestingly, no anti-FLAG antibodies were detectable in cattle up to 21 days post-inoculation.
A24-FLAG G–H loop modeling suggested FLAG was rendered a cryptic site, inaccessible to the host
immune system. These studies demonstrate the FMDV VP1 G–H loop tolerance to substitutions without
detriment to pathogenesis and antigenicity. Finally, A24-FLAG manifested virulence in cattle as
parental virus, and could be distinguished and tracked by tag-speciﬁc anti-sera.
Published by Elsevier Inc.Introduction
Foot-and-mouth disease virus (FMDV) is responsible for the most
economically important viral disease of cattle and other cloven-
hoofed animals (Domingo et al., 2002; Grubman and Baxt, 2004;
Mason et al., 2003; Saiz et al., 2002; Sobrino et al., 2001). It has been
demonstrated that FMDV, the prototypic member of the Aphthovirus
genus of the Picornaviridae, utilizes in vitro four integrin heterodimers
(avb1, avb3, avb6, and avb8) for both attachment to host cells and
subsequent entry via clathrin-coated pits (CCPs) (Baxt and Becker,
1990; Duque and Baxt, 2003; Jackson et al., 2000a,2000b, 2002; 2004;
Neff et al., 1998; O’Donnell et al., 2005; Ruiz-Saenz et al., 2009).
Speciﬁcally, a prominent surface-exposed loop connecting the bG-bH
strands (known as the G–H loop) of the VP1 capsid protein (Acharya
et al., 1989; Logan et al., 1993) contains a highly conserved Arg-Gly-
Asp (RGD) motif, which has been shown to be a recognition sequence
for the av-integrin family of cell surface receptors (Baxt and Becker,
1990; Brown et al., 1999; Burman et al., 2006; Fox et al., 1989). The
VP1 G–H loop can be removed through limited trypsin proteolysis,
resulting in FMDV particles that are considerably less infectious
relative to untreated virions, thus highlighting the importance of thisInc.
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d States.region for productive infection (Strohmaier et al., 1982; Wild and
Brown, 1967). In addition to its importance to infectivity, the VP1
G–H loop has been described as one of the immuno-dominant sites
(antigenic site 1 for serotype A) on the virus particle for several FMDV
serotypes (Acharya et al., 1989; Aggarwal and Barnett, 2002; Barnett
et al., 1989; Baxt et al., 1989; Broekhuijsen et al., 1987; Brown, 1988;
Crowther et al., 1993a, 1993b; Kitson et al., 1990; Mateu et al., 1990;
Thomas et al., 1988b). Additionally, FMDV ﬁeld isolates continually
passaged in cell culture adapt to utilize heparan sulfate (HS) as an
alternative receptor, thus allowing for replication in cells expressing
HS but not av-integrins (CHO K1 cell line), though such viruses
exhibit attenuated pathogenicity (Baranowski et al., 2000; Fry et al.,
1999; Jackson et al., 1996; Sa-Carvalho et al., 1997). Additionally, in
isolated cases, FMDV can adapt to use an as yet unidentiﬁed third
receptor (Baranowski et al., 2000; Zhao et al., 2003) permitting
growth on cell lines devoid of both the integrin heterodimers and
HS such as CHO 677 cells (Esko et al, 1988; Stephens et al., 2006).
We considered various known surface-exposed regions on the
FMDV capsid as sites for the insertion or substitution of a foreign
epitope to develop a recombinant FMDV vector for viral patho-
genesis studies. Given the ﬂexibility of the hypervariable G–H
loop (Acharya et al., 1989), we anticipated that inserting a foreign
tag sequence upstream of the RGD motif would be tolerated by
the virus capsid. The FLAG epitope tag was selected for this proof-
of-concept study based on its established utility in the differen-
tiation of recombinant proteins from wild-type (WT) proteins,
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and Brizzard, 1996; Einhauer and Jungbauer, 2001; Hopp et al.,
1988) and importantly, the successful insertion of the FLAG
epitope into a variety of viruses including FMDV (Baranowski
et al., 2001; Laird and Desrosiers, 2007; Prentoe and Bukh, 2011;
Seago et al., 2012; Tan et al., 2009; Upadhyay et al., 2011).
In this study, we have designed, produced, and characterized a
recombinant FMDV with a FLAG tag embedded in the VP1 G–H loop
just upstream of the RGD motif. The capacity of the FLAG-tagged
virus (A24-FLAG) to replicate to similar titers as the WT progenitor
virus (A24 Cruzeiro) on permissive cell lines was evaluated and
conﬁrmed. Moreover, the embedded FLAG tag was recognized by
anti-FLAG antibodies, which allowed A24-FLAG to be distinguished
by multiple immunological assays. Moreover, genetic and biochem-
ical testing of clinical samples collected from cattle inoculated with
A24-FLAG conﬁrmed that the FLAG epitope was maintained post-
infection of cattle. Although animals inoculated with the A24-FLAG
virus did not develop an anti-FLAG epitope response, the recombi-
nant virus could still be screened with commercially available anti-
FLAG antibodies making this variant virus a useful tool in the study
of FMDV pathogenesis, and to assess the signiﬁcance of antigenic
site 1 in serotype A FMDV.Fig. 1. Design of A24-FLAG. (A) Depiction of the insertion of the FLAG epitope
within P1 region of the FMDV genome, speciﬁcally within the coding sequence for
capsid protein VP1. As indicated, to minimize disruption to the normal structure of
the G–H loop, the second and third amino acids of the FLAG epitope, YK, were
reversed to KY. (B) Side-by-side comparison of the plaque morphologies of
A24-Cru WT and A24-FLAG grown on a monolayer of BHK-21 cells at 24 hpi.
(C) Growth curves of A24-Cru WT and A24-FLAG with measured time points at 0,
4, 8, and 24 hpi. Infections with each virus were performed in triplicate.Results
Derivation and preliminary characterization of FLAG-tagged FMDV.
Several sites within the P1 region of the FMDV genome were
considered for insertion of the FLAG tag. Ultimately, the ﬂexible
and highly variable VP1 G–H loop of the VP1 capsid protein was
selected. As depicted in Fig. 1A, within the A24 Cruzeiro (A24-Cru
WT) backbone, the FLAG octapeptide (DYKDDDDK) replaced eight
amino acid residues (SKYAVGGS) within the G–H loop upstream
of the conserved RGD motif, which represents an antigenically
signiﬁcant site (Baxt et al., 1984; Brown et al., 1999). This site has
also been successfully interchanged between different serotypes
of FMDV (Wang et al., 2012). To minimize potential structural
disruptions caused by the insertion, the YK of the FLAG epitope
was reversed to KY as found in the original portion of the A24-Cru
WT G–H loop sequence (Fig. 1A). Sequencing of the propagated
recombinant virus conﬁrmed the presence of the modiﬁed FLAG
octapeptide (DKYDDDDK) upstream of the RGD motif (Table 1).
Three additional amino acid substitutions were detected; one
each in VP4, VP2, and VP1 (Table 1). All other nucleotides in the
recombinant virus distinct from the consensus sequence for
A24-Cru WT (Accession #AY593768) were silent mutations (Table 1).
The plaque morphologies of the WT and FLAG-tagged virus
(hereafter referred to as A24-FLAG) grown on BHK-21 cells were
compared, which showed similar plaque sizes (Fig. 1B). Addition-
ally, one-step viral growth curves overlap for the WT and
A24-FLAG viruses in BHK-21 cells (Fig. 1C). Sequencing of the
recovered virus after multiple passages conﬁrmed that the
modiﬁcation to the G–H loop was genetically stable (data not
shown). Cumulatively, these preliminary results suggested that
the insertion of the FLAG sequence upstream of the RGD motif did
not alter the growth properties of A24-FLAG relative to its WT
progenitor.
Replacement of FMDV residues within the G–H loop by FLAG tag
renders a virus that maintains integrin recognition for entry into
susceptible cells.
As described in Introduction, FMDV primarily utilizes speciﬁc
av-integrin heterodimers for attachment, though the virus can
mutate to use HS and in some cases an unknown third receptor.To evaluate if the substitution of the FLAG tag upstream of the
RGD motif affects the ability of A24-FLAG to use av-integrin
heterodimers for infection, transient expression of 4 different
integrin heterodimers (avb1, avb3, avb5, and avb6) was achieved
in a cell line (COS-1) devoid of av-integrin heterodimers (data not
shown). The cells were then infected with either A24-Cru WT or
A24-FLAG in the presence of 35S-methionine, the infected cell
lysates radioimmunoprecipitated (RIP) with anti-FMDV anti-sera,
and the resulting eluates examined by autoradiography. FMDV-
speciﬁc viral proteins (3D, VP0, and 2C) were detectable in the
eluates from cells infected with both WT and A24-FLAG that
transiently expressed avb3 or avb6 (Fig. 2A). To a much lesser
extent, some viral protein can be seen in cells expressing avb1. No
FMDV viral proteins were ever observed in RIP eluates from cells
transiently expressing avb5, which is consistent with previous
reports (Duque and Baxt, 2003; Duque et al., 2004). We inferred
from these results that the embedded FLAG epitope upstream of
the RGD motif in the G–H loop did not disrupt the interaction
with the integrin receptor.
To corroborate the ﬁndings of the transient transfection infec-
tion assay (Fig. 2A), BHK-21, CHO K1, and CHO 677 cells were
infected with A24-FLAG in parallel with cultures infected with the
WT virus. In BHK-21 cells, A24-FLAG grew to within one half of a
log of the titer achieved by the WT A24 Cruzeiro (Fig. 2B).
However, only the HS-adapted FMDV VCRM4 variant of O1
Table 1
Sequence comparison of the P1 region of A24-Cru WT and A24-FLAG.
Region A24 Cruzeiro WT A24 Cruzeiro FLAG
Nucleotidea Codonb Amino
acidc
Nucleotidea Codonb Amino
acidc
VP4 G9 ggG – C9 ggC Silent
VP4 A55 Agc S19 G55 Ggc G19
VP2 T275 aTg M92 C275 aCg T92
VP2 G417 cgG – A417 cgA Silent
VP2 A600 caA – G600 caG Silent
VP3 G939 ggG – T939 ggT Silent
VP3 T1416 gcT – G1416 gcG Silent
VP1 G1578 acG – C1578 acC Silent
VP1 A1579 Act T527 G1579 Gct A527
VP1 A1972/
G1973
AGt S658 G1972/
A1973
GAt D658
VP1 C1982 gCt A661 A1982 gAt D661
VP1 T1985/
G1986
gTG V662 A1985/
C1986
gAC D662
VP1 G1988 gGt G663 A1988 gAt D663
VP1 G1991 gGt G664 A1991 gAt D664
VP1 T1993/
C1994
TCa S665 A1993/
A1994
AAa K665
VP1 C2143 Ctg – T2143 Ttg Silent
a Nucleotide different between the viruses followed by number indicating its
position within the coding sequence of the P1 region.
b Lowercase letters indicate the bases shared by the two viruses, and capital
letters indicate the bases that differ between the two viruses.
c One-letter code of the encoded amino acid residues followed by number
indicating residue position in the P1 polypeptide.
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K1 cell line, strongly suggesting that like A24-Cru WT,
A24-FLAG utilizes integrins as the primary receptor for infection
of host cells. Additionally, none of the viruses demonstrated
signiﬁcant replication in the CHO 677 cell line, which is consistent
with what has been previously described for the receptor pre-
ferences of WT A24 and VCRM4. Based on the combined results of
Fig. 2A and B, we concluded the FLAG epitope substitution did not
negatively impact the ability of A24-FLAG to interact with avb3 or
avb6, thus maintaining the established range of cell lines permis-
sive to FMDV infection.
Antigenic detection of A24-FLAG.
To conﬁrm that the introduction of the FLAG epitope within
the antigenic site in the VP1 G–H loop (VP1-FLAG) could be
utilized as a unique marker for detection, the A24-WT and
A24-FLAG viruses were examined by immunocytochemistry
(ICC) using commercially available antibodies against FLAG and
a monoclonal antibody (anti-VP1) generated against an epitope
located downstream of the RGD sequence within serotype A
FMDV. As shown in Fig. 3A, both WT and A24-FLAG infected cells
showed signiﬁcant staining with the anti-VP1 antibody. However,
only A24-FLAG infected cells reacted with the polyclonal rabbit
anti-FLAG antibody.
To corroborate the ICC results, WT and A24-FLAG infected cell
lysates were analyzed by western blot (Fig. 3B). Probing with
anti-VP1 produced an immunoreactive band in both lysates that
migrated at the approximate molecular weight predicted for VP1,
but only the A24-FLAG lysate produced the corresponding band
using the polyclonal anti-FLAG antibody. Considering that the
second and third amino acids in the FLAG epitope were inverted
from DKYDDDDK to DYKDDDDK (Fig. 1A), it seems likely that the
altered amino acid sequence is not recognized by monoclonal
anti-FLAG.
In a further elaboration of the utility of the embedded FLAG
epitope within VP1 for molecular pathogenesis studies, A24-FLAGinfected cells were examined by immunoﬂuorescent microscopy
(IFM) probing with both polyclonal anti-FLAG and monoclonal
anti-VP1. As shown in Fig. 4, A24-FLAG infected cells stained
positive for both FLAG and VP1. Consistent with the supposition
that the FLAG and VP1 anti-sera reacted with FMDV particles
displaying the FLAG epitope as well as the G–H loop epitope
speciﬁc for the monoclonal anti-VP1, the ﬂuorescence associated
with both antibodies overlapped when the individual ﬂuorescent
channels were merged (Fig. 4A). When the assay was repeated
using WT A24 lacking the FLAG epitope, only the VP1 antibody
reacted with the FMDV infected cells (Fig. 4B). We concluded that
the FLAG epitope substitution in A24-FLAG allowed for the
antigenic distinction from WT virus without any discernable
change to the replication cycle of FMDV.A24-FLAG can be neutralized and isolated by polyclonal anti-FLAG.
Given the reactivity of the polyclonal anti-FLAG antibody to
VP1-FLAG in A24-FLAG infected cell lysates, but not VP1 from
A24-Cru WT, we investigated the capacity of polyclonal anti-FLAG
to neutralize A24-FLAG. Preparations of A24-Cru WT and
A24-FLAG were pre-incubated with various dilutions of the FLAG
antibody and were subsequently applied to the LFBK cell line,
which is permissive to all seven serotypes of FMDV and closely
parallels bovine primary kidney cells (Swaney, 1988). Twenty-
four hours post-infection, the virus-infected cells were harvested
and viral protein synthesis was evaluated. Western blots of the
virus-infected cell lysates were probed with an antibody directed
against the FMDV 3D polymerase (3Dpol), which showed that
A24-Cru WT was unaffected by the FLAG anti-sera at any of the
dilutions tested (Fig. 5A, left panel). In strong contrast, A24-FLAG
was effectively neutralized by the FLAG anti-sera at the highest
antibody dilution tested (Fig. 5A, right panel).
The antibody neutralization samples were then tested for
relative virus titer. Titrations revealed that pre-treatment with
the anti-FLAG antibody signiﬁcantly impacted the resulting titer
of A24-FLAG (Fig. 5B). Pre-treatment of A24-FLAG at the highest
dilution of the anti-FLAG antibody (1:100) produced a greater
than 50% reduction in virus titer relative to the titer achieved by
the A24-FLAG virus in the absence of anti-FLAG pre-treatment.
The lowest dilution of the anti-FLAG antibody (1:10) neutralized
A24-FLAG to such a degree that no plaque forming units were
detected during the titration assay. In contrast, A24-Cru WT
experienced no signiﬁcant reduction in virus titer from the anti-
FLAG pre-treatment (Fig. 5B).
Given that the polyclonal anti-FLAG could neutralize
A24-FLAG virus, we wanted to explore if it could similarly be
utilized to purify virus particles from infected cell lysates in vitro.
As such, lysates from A24-FLAG infected cells were immunopre-
cipitated with anti-FLAG coupled to protein A/G beads in parallel
with lysates from cells transiently expressing FLAG-tagged RNA
Helicase A (FLAG-RHA). Western blots of the resulting eluates
probed with anti-FLAG revealed a band corresponding to the
molecular weight of VP1 in lanes containing A24-FLAG infected
lysates (Fig. 4C). Similarly, in lanes containing FLAG-RHA expres-
sing lysates, anti-FLAG detected a band consistent with the
molecular weight of FLAG-RHA. When probed with anti-VP1,
the VP1 band was only detected in the lanes of A24-FLAG infected
cell lysates. When the anti-FLAG immunoprecipitation reaction
was repeated with A24-Cru WT, VP1 was not detected on western
blots of the eluates probed with anti-VP1 and anti-FLAG (data not
shown). We concluded that the FLAG epitope was presented in
the G–H loop of A24-FLAG such that it was accessible to
polyclonal anti-FLAG, permitting the puriﬁcation of A24-FLAG
from infected cell culture.
Fig. 2. Evaluation of growth on established cell lines. (A) Untransfected COS-1 cells and COS-1 cells transiently expressing avb1, avb3, avb5, or avb6 were infected in parallel
with A24-Cru WT and A24-FLAG in the presence of 35S-methionine. The resulting virus-infected cell lysates were immunoprecipitated with serotype A speciﬁc anti-sera,
separated by SDS-PAGE, and examined by autoradiography. Bands corresponding to viral proteins 3D, VP0, and 2C are indicated. (B) Virus titer assays were conducted on
BHK-21, CHO K1, and CHO 677 cells comparing A24-Cru WT, A24-FLAG, and a genetic variant of O1 Campos designed to utilize heparan sulfate as an alternate receptor.
At 24 hpi, plaque-forming units (PFUs) were counted, and virus titers calculated. Titers for virus-infected cells incubated 1 h at 37 1C were subtracted from the titers
determined for samples evaluated at 24 hpi.
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Having established an immunoreactivity proﬁle for A24-FLAG
relative to the WT virus in vitro, we evaluated the kinetics
of the antibody response generated after introduction into cattle.
Virulence of A24-FLAG in cattle was assessed utilizing a well-
established intradermolingual inoculation method (Henderson,
1949). Two cows (bovines #BR10-04 and #BR10-05, hereafter
referred to as bovines #4 and #5) were inoculated with
107 TCID50/animal and infection and clinical signs were mon-
itored daily. Results demonstrated that the two animals devel-
oped clinical FMD and both animals showed vesicles in the feet by
2 or 3 days post-inoculation (dpi). Only bovine #4 showed fever
(440 1C) at 1 dpi. Fig. 6 shows that viremia was detected starting
at 1 dpi and lasted 4–5 days, while virus shedding was detected in
swabs from both animals beginning at 1 dpi. Moreover, biological
ﬂuids collected from the A24-FLAG infected animals showed viral
RNA levels peak between days 1–2 post-inoculation (Fig. 6C),
which was consistent with the pattern observed in cattle inocu-
lated with A24-Cru WT (data not shown).
Plasma and serum collected from cattle inoculated separately
with WT (bovines #393 and #394) and FLAG viruses (bovines #4
and #5) over 21 days exhibited similar antibody responses to
FMDV for both viruses (Fig. 6A). For both A24-Cru WT and
A24-FLAG, anti-FMDV antibodies (antibodies targeted to the viral
RNA dependent RNA polymerase, 3Dpol) were not detected over
background until day 5, peaking at day 7 (Fig. 6A). Afterwards, theantibody response diminished until FMDV antibodies were unde-
tectable at day 21.
The WT and A24-FLAG were also compared for cross-reactivity
with heterologous serotype A FMDV isolates. While homologous
challenge between A24-Cru WT and A24-FLAG showed cross-
protection with relationship values (r1) greater than 0.3, little
cross-reactivity was observed with a small panel of heterologous
related serotype A FMDVs (Fig. 6B). There was some serum cross-
reactivity with A5 Westerwald for one cattle (bovine #393)
inoculated with A24-Cru WT (r1 of 0.840). However, there was
no evidence that the antibody response against A24-FLAG was
more cross-reactive than that of A24-Cru WT (no r1 values
exceeding 0.3).
FLAG epitope is preserved in A24-FLAG post-infection of cattle.
Next, we sought to determine if the FLAG epitope would be
preserved in A24-FLAG upon replication in an animal host (cattle).
RNA extracted from tissue samples and vesicular ﬂuid collected
from cattle infected with A24-FLAG was sequenced after RT-PCR for
the presence of the FLAG tag within the G–H loop. As shown in
Table 2, sequencing of the A24-FLAG VP1 revealed the FLAG epitope
remained intact in virus found in biological samples collected at 2, 3,
and 4 dpi in cattle. To corroborate the genetic analysis, vesicular
ﬂuid collected from the A24-FLAG infected cattle was examined by
western blot probing with anti-FLAG (Fig. 7B). Consistent with the
sequencing data, bands corresponding to the approximate molecular
Fig. 3. Detection of A24-FLAG in vitro. (A) BHK-21 cells grown on coverslips were
infected in parallel with either A24-Cru WT or A24-FLAG and examined by ICC at
5 hpi probing with either anti-VP1 (6HC4) or rabbit polyclonal anti-FLAG (Sigma).
The cells were then incubated with goat-anti-mouse-HRP or goat-anti-rabbit-HRP,
respectively, followed by DAB staining. (B) Serial dilutions of puriﬁed A24-Cru WT
and A24-FLAG viruses were examined by western blot probing with the same
antibodies in A.
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Similarly, the same band was detected in serially diluted prepara-
tions of the same stock of A24-FLAG that was used to inoculate the
cattle from which the biological samples were collected (Fig. 7A).
Absence of FLAG tag seroconversion.
Thus far, the antibody response of A24-FLAG paralleled
A24-Cru WT from which it was derived (Fig. 6). Since previous
studies with other viruses containing FLAG epitope insertion/
substitutions elicited the production of FLAG-targeted antibodies
in vivo, we wanted to investigate if a similar seroconversion
occurred in the cattle infected with A24-FLAG. First, we evaluated
for the presence of antibodies targeted to a mapped region of the
VP1 G–H loop in sera collected from the A24-FLAG inoculated
animals via a competitive ELISA (Fig. 8A). With the competitive
ELISA, plates coated with A24-Cru WT were incubated with a
mixture of sera collected from A24-FLAG infected cattle at either
0 and 28 dpi and a monoclonal antibody that recognizes VP1
(7SF3) (Robertson et al., 1984). The results showed that sera from
A24-FLAG infected bovines at 28 dpi were able to compete
effectively against the VP1 monoclonal antibody (Fig. 8A) similar
to the sera from A24-Cru WT infected bovines (data not shown).
This allowed us to conclude that the presence of the FLAG tag
does not disrupt the reactivity of the G–H loop region with
existing reference sera, which is consistent with results obtained
in vitro.
Having established that the host immune system produced
anti-sera to a mapped region of the G–H loop proximal to the site
of the FLAG substitution, we wanted to determine if the A24-FLAG
infected cattle also generated anti-sera to the FLAG epitope. Assuch, a western blot assay was performed using a commercially
available FLAG-tagged protein: FLAG-bovine alkaline phosphatase
(FLAG-BAP). A dilution series of FLAG-BAP was analyzed by
western blot for reactivity with both the commercially available
mouse monoclonal (M2) and rabbit polyclonal anti-FLAG anti-
bodies. Both anti-sera successfully reacted with FLAG-BAP on the
blots (Fig. 8B). Various dilutions of the sera collected from
A24-FLAG inoculated bovines #4 and #5 failed to react with
FLAG-BAP on the blots (data not shown). Finally, undiluted sera
from bovines #4 and #5 were used to probe the blots, which
similarly failed to react with FLAG-BAP (Fig. 8B). Based on the
results of the ELISA and western blot panel (Fig. 8), we concluded
that seroconversion to the FLAG epitope did not occur in
A24-FLAG infected cattle.
Structural analysis of the FLAG epitope within the G–H loop.
With the successful detection, neutralization, and immuno-
precipitation of A24-FLAG using FLAG polyclonal anti-sera, but
the lack of seroconversion to the FLAG epitope in bovines
inoculated with A24-FLAG, we sought to determine why the host
immune system did not recognize the FLAG epitope. As such, we
examined structural models of the G–H loop containing the FLAG
tag. Using the coordinates from the solved structure for FMDV O1/
BFS 1860/UK/67 (Protein Databank 1FOD) (Logan et al., 1993) as a
template and the VP1 amino acid sequences of the WT and
A24-FLAG, homology models were generated of the G–H loop
(Fig. 8C). The structures of the G–H loops of the homologous
viruses were similar, but not identical. Notably, the region with
the FLAG epitope substitution was folded inward on itself,
potentially rendering the site cryptic and inaccessible to detection
by the host immune system. Molecular dynamics simulations
(Amber 10, Case et al., 2008) were also performed using 1FOD
(Logan et al., 1993) with the A24 sequence modeled into the G–H
loop and the serotype O loop modiﬁed to contain the FLAG
sequence as inserted into A24 (O1-FLAG). Fig. 8D shows these
loops after 4 ns simulation. Notably, the O1-FLAG loop collapsed
in on itself (to make salt bridge interactions between the FLAG
sequence and other residues in the loop). While keeping in mind
that this is in silico modeling performed in the absence of X-ray
structures for the A24-Cru WT and A24-FLAG, it seems likely that
animals infected with the A24-FLAG virus do not seroconvert to
recognize the FLAG epitope due to the collapsed conformation
assumed by a portion of the sequence in the G–H loop.Discussion
Here, we sought to generate a stably tagged FMDV particle
that could be broadly utilized in a variety of molecular assays
with the aim of further delineating viral pathogenesis both in vitro
and in vivo. To that end, we designed and characterized in tissue
culture and in the natural host, a novel recombinant FMD virus
with a FLAG epitope embedded within the VP1 G–H loop. While
multiple sites on the capsid surface were considered for mole-
cular manipulation, the hypervariable sequence upstream of the
RGD motif was selected given the fact that these residues tolerate
a high degree of variation, and are exposed on the virus capsid
surface. Furthermore, this antigenic site, indeed the entire G–H
loop, is not absolutely necessary for the development of protec-
tive immunity in cattle or pigs (Fowler et al., 2008, 2010; Rieder
et al., 1994). Moreover, we were encouraged by three reports: the
ﬁrst describing the successful replacement of a portion of the G–H
loop encompassing the conserved RGD motif and RGDþ1 leucine
with FLAG just downstream and adjacent to the site we selected
for substitution (Baranowski et al., 2001), a second where FLAG
Fig. 4. Detection of A24-FLAG by immunoﬂuorescent microscopy in vitro. (A) LFBK cells grown on glass coverslips were mock-infected (top row) or infected with A24-FLAG
for 5 h (bottom row) and subsequently simultaneously probed with anti-FLAG (green) and anti-VP1 (red). (B) Same as in A except the cells were infected with A24-Cru WT.
Mounting medium from all experiments was supplemented with DAPI nuclear stain (blue).
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(which was published while this manuscript was under revision,
Seago et al., 2012), and the third detailing that a speciﬁc
neutralizing epitope within this region was successfully
exchanged between FMDV serotypes O and Asia1, which was
stably maintained, and expanded the immunoreactivity of the
recombinant virus (Wang et al., 2012). Of note, the results of
Baranowski et al. (2001) showed the G–H loop could tolerate the
presence of the foreign epitope replacing amino acid residues,
which participate in the recognition of the virus receptor
(Baranowski et al., 2001; Dicara et al., 2008; Jackson et al., 2000b).
The stated goal of this endeavor was to produce a FMDV
particle with a unique reactivity proﬁle that could be tracked
in vitro and in vivo without detriment to normal FMDV pathogen-
esis. The recombinant marker A24-FLAG with the unique sub-
stitution resulted in a virus that achieved high titers and formed
plaques similar to that of parental A24-Cru on BHK-21 cell
monolayers. Regardless of the proximity of the foreign sequence
to the cell receptor binding site (RGD motif), and the presence of
highly charged residues in the foreign peptide, the FLAG substitu-
tion neither affected the virus interaction with its cognate cell
receptors avb3 and avb6 integrins (Burman et al., 2006; Jackson
et al., 2000b; Neff et al., 2000), nor altered the established array of
cell lines susceptible and refractory to FMDV infection. Of sig-
niﬁcance was the observation that the A24-FLAG virus main-
tained reactivity with established reference sera to VP1 but
expanded reactivity to include polyclonal anti-FLAG as observedby IFM, ICC, and western blot assays. Importantly, given the
proximity of the substitution to the RGD motif, the expanded
reactivity was not at the expense of the recognition of integrins as
the primary receptor. The positive reactivity with the polyclonal
anti-FLAG successfully provided a means by which to differentiate
the WT and FLAG-tagged virus particles in vitro as well as in vivo.
Moreover, the anti-FLAG successfully neutralized A24-FLAG but
not A24-Cru WT when treated prior to infection. By extension,
A24-FLAG could be isolated from infected samples via FLAG anti-
sera providing yet another advantage over WT particles. Thus, the
tolerated substitution of the FLAG octapeptide within the G–H
loop has allowed for the detection, tracking, neutralization, and
puriﬁcation of the recombinant marker virus distinct from its WT
progenitor.
While the FLAG epitope has previously been incorporated into
locations on the FMDV capsid (Baranowski et al., 2001; Seago
et al., 2012), this study represents the ﬁrst instance where a FLAG-
tagged FMDV particle was examined in the natural host. Given
the reported success for tag epitope insertions into the genomes
of several other viruses (Laird and Desrosiers, 2007; Plemper
et al., 2002; Prentoe and Bukh, 2011; Tan et al., 2009), it was
hoped that the FLAG tag substitution would also redirect the host
immune response to other antigenic site/s contained on the FMDV
capsid (Baxt et al., 1984, 1989; Brown et al., 1999). While cattle
infected with A24-FLAG induced levels of neutralizing antibodies
comparable to the parental virus, we were unable to demonstrate
the presence of host antibodies targeted to FLAG in infected
Fig. 5. Anti-FLAG antibodies can be used to neutralize and immunoprecipitate A24-FLAG but not A24-Cru WT. (A) The level of viral protein synthesis achieved for A24-Cru
WT and A24-FLAG at 24 hpi after a virus neutralization assay that used anti-FLAG was evaluated by western blot probing with anti-FMDV 3Dpol. Loading equivalency
between lanes was conﬁrmed by probing with anti-tubulin-a. (B) The relative virus titers achieved by A24-Cru WT and A24-FLAG after the virus neutralization assay was
determined by virus titer assay (see Materials and methods). (C) LFBK cells were infected with A24-FLAG for 5 h and infected lysates were subject to immunoprecipitation
with polyclonal anti-FLAG. The collected ﬂow-through (FT), pooled washes (W), and eluate (EL) were examined by western blot probing with anti-VP1 (top) and anti-FLAG
(bottom). FLAG-tagged VP1 is indicated by an arrowhead. To conﬁrm the speciﬁcity of the anti-FLAG immunoprecipitation, LFBK cells expressing FLAG-tagged RHA were
immunoprecipitated by the same method, and the resulting samples were analyzed on the same western blot as the A24-FLAG-containing samples. FLAG-tagged RHA is
indicated by an arrow. Cross-reacting heavy chain and light chain from the immunoprecipitation reaction are indicated by an asterisk and a ﬁlled circle, respectively.
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polyclonal anti-FLAG sera. Molecular modeling and simulation
data suggested that a signiﬁcant portion of the FLAG epitope was
invaginated. Plausibly, the predicted invagination could impair
the recognition of this epitope by the immune system of the cattle
that were exposed to this virus. Seemingly though, this hypoth-
esis is contradictory to the neutralization and immunoprecipita-
tion of A24-FLAG by polyclonal anti-FLAG. However, the ﬂexibility
afforded antibodies in solution may allow for the recognition of
an invaginated FLAG tag that a B-cell receptor ﬁxed to a leukocyte
surface could not.
The toleration of the FLAG substitution within the hypervari-
able region upstream of the RGD motif also adds to the body of
publications detailing the antigenicity of the FMDV capsid. Early
work with FMDV identiﬁed several major antigenic sites on FMDV
particles critical to antibody neutralization. The conserved RGD
motif in the G–H loop of VP1 has been reported to be the major
immuno-dominant site on the capsid of all seven serotypes of
FMDV (Barnett et al., 1989; Baxt et al., 1984; Broekhuijsen et al.,
1987; Brown, 1988; Crowther et al., 1993a, 1993b; Kitson et al,
1990; Mateu et al., 1990; Thomas et al., 1988a, 1988b). However,
other reports have suggested just the opposite: that the G–H loop
is dispensable in the context of the virus-host immune response.
For example, vaccines prepared with chimeric FMDV capsids with
the G–H loop exchanged with that of a different serotype were
better protected against challenge with viruses homologous to
the chimera backbone and not with the virus type providing the
heterologous G–H loop (Fowler et al., 2008; Rieder et al., 1994).
More recent work has revealed little to no effect to the elicitation
of a protective immune response in animals vaccinated with atype A FMDV variant lacking a large portion of the VP1 G–H loop
(Fowler et al., 2010). Our results showing that the recombinant
A24-FLAG virus was capable of inducing an immune response in
cattle nearly indistinguishable from that of the parental virus
serves to reinforce the contention that this region of the capsid
surface can be modiﬁed without detriment of the development of
a robust neutralizing response. Indeed, given its apparent dis-
pensability, additional epitope tags should be explored as possible
molecular markers for tracking virus in vitro and in vivo, but also
for possible seroconversion to the tag.
Taken together, the results reported here highlight the consider-
able utility of recombinant FMDVs with embedded sequence tags
within capsid loop regions for investigations of FMDV virulence
in vitro and in vivo. The FLAG epitope being unique without a
naturally occurring counterpart allows FLAG-containing FMDV par-
ticles to be tracked and neutralized using no virus-speciﬁc anti-sera,
and also provides an alternative single step method for virus
puriﬁcation from infected cell and tissue lysates unavailable for
the parental virus. Importantly, the similar immune response
elicited by the mutant and parental virus in cattle suggests that
multiple epitope tags in the FMDV VP1 G–H loop could be utilized to
trace the virus in susceptible animals for pathogenesis studies.
Materials and methods
Materials
FLAG-tagged BAP protein, 3X FLAG peptide, bovine serum
albumin (BSA), glycine, normal goat serum, and paraformaldehyde
were purchased from Sigma (St. Louis, MO). The Vectastain kit was
Fig. 6. A24-FLAG and A24-Cru WT elicit similar immune and physiological responses in infected cattle. (A) Comparison of the antibody response elicited by cattle
homologously challenged with A24-Cru WT and A24-FLAG, and examined at 0, 7, 14, and 22 dpi. (B) Examination of the cross-reactivity of sera collected from A24-Cru WT
and A24-FLAG inoculated cattle with heterologous serotype A FMDV isolates. Signiﬁcant r1 value:r0.3¼no relationship, 40.3¼coverage. Signiﬁcant R value: 464%.
(C) The levels of viral RNA detected in sera, saliva, and nasal swabs collected over the course of 8 days post-inoculation with A24-FLAG in bovines #4 and #5.
Table 2
DNA sequencing of VP1 G–H loop of virus in ﬂuids and tissue collected from A24-FLAG infected cattle.
Cow ID # Extracted material Day post-inoculation Sequence obtained Silent mutations
10-04 Tissue-left rear foot 3 GTDKYDDDDKGRRGD 3906, 3919
Tissue-left rear foot 4 GTAKYDDDDKGRRGD 2775, 3906, 4685
10-05 Vesicular ﬂuid-right rear foot 2 GTAKYDDDDKGRRGD 3906
Vesicular ﬂuid-left front foot 3 GTAKYDDDDKGRRGD 3228, 3906
Tissue-left front foot 3 GTDKYDDDDKGRRGD 2925, 3906
Tissue-left rear foot 3 GTAKYDDDDKGRRGD 3906
FMDV A24 Cruzeiro Reference Sequence – GTSKYAVGGSGRRGD –
FMDV A24-FLAGReference Sequence – GTDKYDDDDKGRRGD –
P. Lawrence et al. / Virology 436 (2013) 150–161 157purchased from Vector Laboratories (Burlingame, CA). Immulon HB
ELISA plates were purchased from Thermo Scientiﬁc (Rochester, NY).
SureBlue Reserve substrate and BlueStop buffer were purchased
from KPL (Gaithersburg, MD). Protein A/G Plus agarose was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA). ProLong
antifade mounting medium supplemented with DAPI stain was
purchased from Invitrogen (Carlsbad, CA).Antibodies
Rabbit polyclonal anti-FLAG, HRP-conjugated mouse monoclonal
(M2) anti-FLAG, and anti-tubulin-a were purchased from Sigma
(St. Louis, MO). Goat-anti-rabbit, goat-anti-mouse, and goat-anti-
bovine secondary antibodies conjugated to HRP were purchased
from Bethyl Laboratories (Montgomery, TX). AlexaFluor-488
Fig. 7. FLAG epitope detection in virus present in biological samples collected from
A24-FLAG infected cattle. (A) Dilution series of puriﬁed stock of A24-FLAG used to
inoculate bovines #4 and #5 (Fig. 6) examined by western blot probing with
polyclonal anti-FLAG. (B) Vesicular ﬂuid (VF) collected from bovine #5 at day 2
(D2) and day 3 (D3) post-inoculation were examined by western blot probing with
polyclonal anti-FLAG and Coomassie blue (CB) staining. FLAG-tagged VP1 is
indicated by an arrow. An uncleaved P1 product is indicated by an arrowhead.
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anti-mouse were purchased from Invitrogen (Carlsbad, CA). Mouse
monoclonal anti-FMDV 3Dpol was generously provided Dr. Alfonso
Clavijo (National Centre for Foreign Animal Diseases, Canada).
Mouse monoclonal anti-FMDV VP1 (6HC4 and 7SF3) were generated
as previously described (Robertson et al., 1984).
Cells, viruses, and plasmids
The BHK-21 cell line was purchased from the American Tissue
Collection Company (ATCC; Manassas, VA) and cultured in
Dulbecco’s minimal eagle medium (DMEM) supplemented with
10% calf serum with 1% antibiotic/antimycotic (A/A) and incu-
bated at 37 1C with 5% CO2. The LFBK cell line was generated as
previously described (Swaney, 1988), and cultured in DMEM
supplemented with 10% fetal calf serum and incubated at 37 1C
with 5% CO2. The Chinese hamster ovary (CHO) K1 and CHO 677
cell lines were originally acquired from Esko et al. (1988) and
cultured in Ham’s minimal essential medium (Gibco) supplemen-
ted with 10% fetal calf serum and incubated at 37 1C with 5% CO2.
FMDV A24 Cruzeiro ﬁeld strain was derived from pA24-Cru
(Rieder et al., 2005) and the FMDV VCRM4 virus was derived
from O1 Campos as previously described (Neff et al., 1998).
Virus titer assay
Following virus absorption for 1 h (h), the inoculum was
removed, and the cells were washed in a mild acid solution
followed by a wash in virus growth media (VGM). VGM was
added to each well and the cells were returned to 37 1C. After 24 h
at 37 1C, virus-infected cells were harvested and viral titers were
determined by plaque assay as previously described (Rieder et al.,
1993). Plates were ﬁxed, stained with crystal violet (0.3% in
Histochoice; Amresco, Solon, OH), and the plaques were counted.
The values calculated for the number of plaque-forming units(PFUs) per milliliter (mL) were plotted using Microsoft Excel
(Microsoft Corporation, Redmond, WA). All assays were per-
formed in triplicate.
Transient transfection-infection assay
Assay was conducted as previously described (Neff et al.,
2000). Brieﬂy, COS-1 cells were transfected with two plasmids
encoding either full-length av-integrin or 1 of 4 full-length
b integrins (b1, b3, b5, or b6). The cells were then infected with
A24-Cru WT, A24-FLAG, or VCRM4 viruses at a MOI of 1 in
35S-methionine containing media. Subsequently, virus-infected
cell lysates were examined by radioimmunoprecipitation for
virus-speciﬁc bands: 3D, VP0, and VP1-3 as previously described.
Immunoﬂuorescent microscopy
LFBK cells grown on glass coverslips were mock-infected or
infected with A24-Cru WT and A24-FLAG for 1, 3, and 5 h at 37 1C.
At each time point, the cells were ﬁxed with 4% paraformaldehyde
(Sigma), permeabilized with 0.1% Triton-X100 in PBS on ice, and
blocked with buffer containing 3% BSA, 0.3 M glycine, and 10%
normal goat serum. The cells were then probed simultaneously
with polyclonal anti-FLAG (Sigma) and monoclonal anti-VP1
(6HC4) followed by goat-anti-rabbit-AF488 and goat-anti-
mouse-AF594 (Invitrogen) with multiple PBS washes after each
antibody treatment. Finally, the coverslips were air-dried and
mounted onto glass slides with ProLong antifade mounting
medium supplemented with DAPI stain (Invitrogen). Samples
were examined using an Olympus ﬂuorescent microscope with
a 100X oil immersion objective.
Virus neutralization assay
A24-Cru WT and A24-FLAG were pre-incubated with antibo-
dies directed against the FLAG epitope at dilutions of 1:100, 1:50,
1:25, or 1:10. Alternatively, the viruses were pre-incubated with
an antibody targeted to a region within the VP1 G–H loop at
dilutions of 1:100, 1:50, 1:10, or 1:5. After incubating for 1 h at
RT, viruses were applied to LFBK cells and incubated 24 h at 37 1C.
Virus-infected cell lysates were harvested and viral protein
synthesis was evaluated by western blot probing with anti-
FMDV 3Dpol. Equivalent loading was conﬁrmed by re-probing
with anti-tubulin-a (Sigma).
Virus immunoprecipitation
A24-FLAG infected cell pellets were lysed using ‘‘FLAG lysis
buffer’’ (Sigma), pre-cleared with normal rabbit serum (Pierce)
and protein A/G beads (Santa Cruz Biotechnology), and incubated
with polyclonal anti-FLAG (Sigma) and protein A/G beads at 4 1C
for 24 h. After incubation with anti-FLAG bound beads, the
samples were centrifuged at 2500 rpm for 5 min at RT, and
the ﬂow-through was collected for each sample. Afterwards, the
samples were washed no less than ﬁve times with ‘‘FLAG 1X wash
buffer’’ (Sigma), and the collected washes were pooled. Elution
was performed by incubating samples with a 3X FLAG peptide
(Sigma). The collected ﬂow-through, pooled washes, and eluate
were then examined by western blot.
Western blot
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis) was carried out using a 12% Nu-PAGE s pre-cast gel
system (Invitrogen). Subsequently, the separated proteins
were electro-blotted onto a nitrocellulose membrane (Sigma).
Fig. 8. Sera collected from A24-FLAG infected cattle do not react with FLAG epitope. (A) Competitive ELISA where A24-Cru WT and A24-FLAG viruses were incubated with
equal quantities of day 0 (hatched) and 28 (black) sera collected from inoculated cattle and a reference mouse monoclonal antibody for VP1. Subsequently, the mixtures
were tested for reactivity with HRP-conjugated goat-anti-mouse secondary antibody. (B) FLAG-tagged BAP protein was examined by western blot at two different
concentrations (0.5 and 1 mg) and probed with rabbit polyclonal anti-FLAG, mouse monoclonal anti-FLAG, or the day 28 sera obtained from cattle (bovines #4 and #5)
infected with A24-FLAG. (C) Homology models of the VP1 G–H loop of A24-Cru WT and A24-FLAG were generated using the coordinates from the crystal structure of FMDV
O1/BFS 1860/UK/67 (Accession 1FOD). The RGD motif (blue, green, red, respectively), RGDþ4 L150 position (pink), and FLAG sequence site (purple) are indicated.
(D) Overlapping cartoon of the protomeric subunit with the G–H loop (after 4 ns simulation) highlighted by color: O1/BFS 1860/UK/67 (blue), A24-Cru WT (light cyan), and
O1-FLAG (yellow, FLAG sequence in red).
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detected with primary antibodies at indicated dilutions followed
by goat-anti-rabbit or goat-anti-mouse antibodies conjugated
with HRP (Bethyl). Cellular tubulin, employed as an internal loading
control protein, was detected with anti-tubulin-a (Sigma).
The HRP-conjugated secondary antibodies were reacted with the
WestDura SuperSignal chemiluminescent reagent (Thermo Scienti-
ﬁc) according to the manufacturer’s instructions and visualized on
X-ray ﬁlm (X-Omat; Kodak, N.Y., USA).Competitive ELISA
Nunc Maxisorp ELISA plates were coated with 2  109 PFU/mL
A24-Cru WT virus stock at 1:1000 and incubated overnight at
4 1C. Plates were washed with PBS-T and pre-mixed solutions
containing reference and test sera (1:80) and anti-VP1 (7SF3)
(1:10) were added and incubated 1 h at 37 1C. Goat-anti-mouse-
HRP (1:2000) in 5% milk in PBS-T was added and the plates were
incubated at 37 1C for an additional hour with subsequent
P. Lawrence et al. / Virology 436 (2013) 150–161160washing. Afterwards, 100 ml of SureBlue Reserve Substrate (KPL)
was added to each well and incubated for 1 h at RT. The reactions
were stopped with 50 ml of TMB BlueStop buffer (KPL) and the
plates were read at 630 nm.
Virulence of A24-FLAG virus in cattle
Animal experiments were performed under biosafety level
3 conditions in the animal facilities at PIADC following a protocol
approved by the Institutional Animal Care and Use Committee.
Two steers (300–400 kg) were infected per the intradermolingual
inoculation method (Henderson, 1949) with approximately
107 TCID50 per cattle, diluted in MEM. For 8 days after inoculation,
animals were clinically examined, including rectal temperature
recordings and serum, oral and nasal swabs collection. After
collection, clinical samples were aliquotted and frozen at 70 1C.
One serum and one swab aliquot were used to perform viral
titration by rRT-PCR as described previously (Pacheco et al., 2010).
Clinical scoring was made based on lesions present in each foot,
with a maximum of 4.
Structural analysis
The amino acid sequences of A24-Cru WT and A24-FLAG were
used to construct homology models of the respective VP1 capsid
proteins using the web algorithm Geno3D (Combet et al., 2002),
which generates 10 most likely structures for the amino acid
sequence supplied. Coordinates from the solved structure of the
major immunogenic site of FMDV O1/BFS 1860/UK/67 (Accession
1FOD) served as a template for the homology models (Logan et al.,
1993). The 10 most likely structures were examined using Deep
View (Guex and Peitsch, 1997; Kaplan and Littlejohn, 2001), and a
consensus structure for each amino acid sequence was selected.
Molecular dynamics (MD) simulations were performed using
1FOD (Logan et al., 1993) allowing the G–H loop to move
independently against the static capsid background with the
A24 sequence modeled into the G–H loop and the serotype O
loop modiﬁed to contain the FLAG sequence as inserted on A24
(O1-FLAG). The loops were subjected to 4 ns MD simulations
using the Parm99 force-ﬁeld implemented in AMBER 10 package
(Case et al., 2008). The models were fully solvated in TIP3P waters
in a rectangular box extending by 10 A˚ and Naþ ions were used to
neutralize the surface charge of the protein. Long-range electro-
static interactions were treated with periodic boundary condi-
tions and Ewald sums as implemented in the AMBER package. The
simulations were carried out at 310 K in the NVT ensemble with
an integration time step of 2 fs and the non-bonded cut off
distance was maintained at 12 A˚. Long-range electrostatics were
included using PME method. Prior to simulation the system was
minimized in two steps, ﬁrst the energy from water was mini-
mized by keeping the protein restrained followed by the mini-
mization of water and protein simultaneously. The system was
heated to 310 K and equilibrated for 500 ps before performing an
unrestrained 4 ns production run.Acknowledgments
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